vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and UNIVEST FINANCIAL Corp (UVSP). Click either name above to swap in a different company.
UNIVEST FINANCIAL Corp is the larger business by last-quarter revenue ($87.5M vs $44.9M, roughly 1.9× AbCellera Biologics Inc.). UNIVEST FINANCIAL Corp runs the higher net margin — 31.0% vs -19.9%, a 50.9% gap on every dollar of revenue. Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 10.2%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Univest Financial Corp is a U.S. regional financial services holding company based in Pennsylvania. It offers banking, wealth management, insurance, and lending solutions for individual consumers, SMEs, and institutional clients across its Mid-Atlantic operating regions.
ABCL vs UVSP — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $87.5M |
| Net Profit | $-8.9M | $27.1M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | — |
| Net Margin | -19.9% | 31.0% |
| Revenue YoY | 788.4% | — |
| Net Profit YoY | 73.9% | — |
| EPS (diluted) | $-0.03 | $0.96 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $87.5M | ||
| Q4 25 | $44.9M | $84.6M | ||
| Q3 25 | $9.0M | $83.2M | ||
| Q2 25 | $17.1M | $81.0M | ||
| Q1 25 | $4.2M | $79.2M | ||
| Q4 24 | $5.0M | $76.8M | ||
| Q3 24 | $6.5M | $73.4M | ||
| Q2 24 | $7.3M | $72.0M |
| Q1 26 | — | $27.1M | ||
| Q4 25 | $-8.9M | $22.7M | ||
| Q3 25 | $-57.1M | $25.6M | ||
| Q2 25 | $-34.7M | $20.0M | ||
| Q1 25 | $-45.6M | $22.4M | ||
| Q4 24 | — | $18.9M | ||
| Q3 24 | $-51.1M | $18.6M | ||
| Q2 24 | $-36.9M | $18.1M |
| Q1 26 | — | — | ||
| Q4 25 | -63.7% | 34.0% | ||
| Q3 25 | -851.8% | 38.5% | ||
| Q2 25 | -290.2% | 30.9% | ||
| Q1 25 | -1479.6% | 34.8% | ||
| Q4 24 | — | 30.9% | ||
| Q3 24 | -1439.4% | 31.9% | ||
| Q2 24 | -1276.2% | 31.4% |
| Q1 26 | — | 31.0% | ||
| Q4 25 | -19.9% | 26.9% | ||
| Q3 25 | -637.8% | 30.8% | ||
| Q2 25 | -203.3% | 24.7% | ||
| Q1 25 | -1077.2% | 28.3% | ||
| Q4 24 | — | 24.7% | ||
| Q3 24 | -785.4% | 25.3% | ||
| Q2 24 | -504.3% | 25.1% |
| Q1 26 | — | $0.96 | ||
| Q4 25 | $-0.03 | $0.78 | ||
| Q3 25 | $-0.19 | $0.89 | ||
| Q2 25 | $-0.12 | $0.69 | ||
| Q1 25 | $-0.15 | $0.77 | ||
| Q4 24 | — | $0.64 | ||
| Q3 24 | $-0.17 | $0.63 | ||
| Q2 24 | $-0.13 | $0.62 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $222.4M |
| Total DebtLower is stronger | — | $201.2M |
| Stockholders' EquityBook value | $966.9M | $952.0M |
| Total Assets | $1.4B | $8.1B |
| Debt / EquityLower = less leverage | — | 0.21× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $222.4M | ||
| Q4 25 | $128.5M | — | ||
| Q3 25 | $83.2M | — | ||
| Q2 25 | $92.4M | — | ||
| Q1 25 | $159.3M | — | ||
| Q4 24 | $156.3M | — | ||
| Q3 24 | $126.6M | — | ||
| Q2 24 | $148.3M | — |
| Q1 26 | — | $201.2M | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $952.0M | ||
| Q4 25 | $966.9M | $943.3M | ||
| Q3 25 | $964.0M | $933.2M | ||
| Q2 25 | $1.0B | $916.7M | ||
| Q1 25 | $1.0B | $903.5M | ||
| Q4 24 | $1.1B | $887.3M | ||
| Q3 24 | $1.1B | $877.1M | ||
| Q2 24 | $1.1B | $854.1M |
| Q1 26 | — | $8.1B | ||
| Q4 25 | $1.4B | $8.4B | ||
| Q3 25 | $1.4B | $8.6B | ||
| Q2 25 | $1.4B | $7.9B | ||
| Q1 25 | $1.3B | $8.0B | ||
| Q4 24 | $1.4B | $8.1B | ||
| Q3 24 | $1.4B | $8.2B | ||
| Q2 24 | $1.4B | $7.9B |
| Q1 26 | — | 0.21× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | — |
| Free Cash FlowOCF − Capex | $-44.6M | — |
| FCF MarginFCF / Revenue | -99.4% | — |
| Capex IntensityCapex / Revenue | 21.9% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-34.7M | $101.5M | ||
| Q3 25 | $-52.6M | $32.0M | ||
| Q2 25 | $-32.4M | $23.3M | ||
| Q1 25 | $-11.6M | $15.6M | ||
| Q4 24 | $-108.6M | $75.1M | ||
| Q3 24 | $-28.9M | $38.9M | ||
| Q2 24 | $-30.0M | $-3.4M |
| Q1 26 | — | — | ||
| Q4 25 | $-44.6M | $96.9M | ||
| Q3 25 | $-61.5M | $31.4M | ||
| Q2 25 | $-45.8M | $21.9M | ||
| Q1 25 | $-22.2M | $13.7M | ||
| Q4 24 | $-187.0M | $72.0M | ||
| Q3 24 | $-47.4M | $38.3M | ||
| Q2 24 | $-50.1M | $-4.2M |
| Q1 26 | — | — | ||
| Q4 25 | -99.4% | 114.6% | ||
| Q3 25 | -687.0% | 37.7% | ||
| Q2 25 | -267.9% | 27.0% | ||
| Q1 25 | -524.0% | 17.2% | ||
| Q4 24 | -3702.8% | 93.8% | ||
| Q3 24 | -728.4% | 52.2% | ||
| Q2 24 | -683.8% | -5.9% |
| Q1 26 | — | — | ||
| Q4 25 | 21.9% | 5.4% | ||
| Q3 25 | 99.7% | 0.7% | ||
| Q2 25 | 78.2% | 1.7% | ||
| Q1 25 | 251.1% | 2.5% | ||
| Q4 24 | 1552.7% | 4.0% | ||
| Q3 24 | 284.6% | 0.8% | ||
| Q2 24 | 274.6% | 1.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | 4.46× | ||
| Q3 25 | — | 1.25× | ||
| Q2 25 | — | 1.16× | ||
| Q1 25 | — | 0.70× | ||
| Q4 24 | — | 3.97× | ||
| Q3 24 | — | 2.09× | ||
| Q2 24 | — | -0.19× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABCL
Segment breakdown not available.
UVSP
| Net Interest Income | $63.4M | 72% |
| Noninterest Income | $24.1M | 28% |
